It's not every year that a healthcare company makes Consumer Reports' annual "naughty or nice" list, but this year, CVS Health (CVS -0.86%) made the nice list thanks to its decision to stop selling tobacco-related products in its stores.
CVS Health's decision to eliminate tobacco is controversial to some because it immediately lops $2 billion in annual sales off the company's top line, but the move could end up being a big, long-term win for the pharmacy store chain. In the following video, healthcare analyst Michael Douglass and healthcare contributor Todd Campbell discuss the reasoning behind CVS Health's decision and whether or not they believe investors should consider putting CVS Health on their wish lists.
